Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer
出版年份 2022 全文链接
标题
Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer
作者
关键词
-
出版物
MOLECULAR & CELLULAR PROTEOMICS
Volume 21, Issue 10, Pages 100409
出版商
Elsevier BV
发表日期
2022-09-07
DOI
10.1016/j.mcpro.2022.100409
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Synergistic pharmacodynamic effects of gemcitabine and fibroblast growth factor receptor inhibitors on pancreatic cancer cell cycle kinetics and proliferation
- (2021) Qingxiang Lin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Estimated Projection of US Cancer Incidence and Death to 2040
- (2021) Lola Rahib et al. JAMA Network Open
- OSpaad: An online tool to perform survival analysis by integrating gene expression profiling and long‐term follow‐up data of 1319 pancreatic carcinoma patients
- (2020) Guosen Zhang et al. MOLECULAR CARCINOGENESIS
- Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotype
- (2019) Mehdi El Amrani et al. MOLECULAR CARCINOGENESIS
- Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma
- (2019) Rebecca L. Porter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2′,2′-difluorodeoxyuridine and their nucleotides
- (2018) Ellen J. B. Derissen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors
- (2018) Nan-nan Wang et al. EXPERIMENTAL CELL RESEARCH
- Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy
- (2018) Yue-Qin Li et al. IUBMB LIFE
- Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells InvestigatedviaLarge-Scale, Ion-Current-Based Quantitative Proteomics (IonStar)
- (2018) Xue Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- IonStar enables high-precision, low-missing-data proteomics quantification in large biological cohorts
- (2018) Xiaomeng Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
- (2018) Xu Zhu et al. Frontiers in Pharmacology
- Surfactant Cocktail-Aided Extraction/Precipitation/On-Pellet Digestion Strategy Enables Efficient and Reproducible Sample Preparation for Large-Scale Quantitative Proteomics
- (2018) Shichen Shen et al. ANALYTICAL CHEMISTRY
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
- (2017) E Hessmann et al. GUT
- An IonStar Experimental Strategy for MS1 Ion Current-Based Quantification Using Ultrahigh-Field Orbitrap: Reproducible, In-Depth, and Accurate Protein Measurement in Large Cohorts
- (2017) Xiaomeng Shen et al. JOURNAL OF PROTEOME RESEARCH
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Gemcitabine Enhances Kras-MEK–Induced Matrix Metalloproteinase-10 Expression Via Histone Acetylation in Gemcitabine-Resistant Pancreatic Tumor-initiating Cells
- (2017) Kazuya Shimizu et al. PANCREAS
- Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
- (2017) Leore T. Geller et al. SCIENCE
- Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells
- (2017) Xilong Sun et al. Human Cell
- S100A4 in cancer progression and metastasis: A systematic review
- (2017) Fei Fei et al. Oncotarget
- Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
- (2017) Ru Chen et al. Scientific Reports
- Pancreatic Cancer Chemoresistance to Gemcitabine
- (2017) Manoj Amrutkar et al. Cancers
- TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells
- (2016) Jeffrey Q. Nguyen et al. CANCER BIOLOGY & THERAPY
- ATP7B expression confers multidrug resistance through drug sequestration
- (2016) F M Moinuddin et al. Oncotarget
- The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC)
- (2016) Zhuang-hua Li et al. Journal of Cancer
- The Genotype-Tissue Expression (GTEx) Project
- (2015) Latarsha J. Carithers et al. BIOPRESERVATION AND BIOBANKING
- Aldehyde dehydrogenases and cancer stem cells
- (2015) Xia Xu et al. CANCER LETTERS
- Gemcitabine resistance in pancreatic ductal adenocarcinoma
- (2015) Yoav Binenbaum et al. DRUG RESISTANCE UPDATES
- Experimental Null Method to Guide the Development of Technical Procedures and to Control False-Positive Discovery in Quantitative Proteomics
- (2015) Xiaomeng Shen et al. JOURNAL OF PROTEOME RESEARCH
- Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine
- (2015) Ming-Chen Yang et al. Molecular Cancer
- A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines
- (2015) YI XIANG et al. ONCOLOGY REPORTS
- Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway
- (2015) T Namba et al. Cell Death & Disease
- The Genotype-Tissue Expression (GTEx) Project
- (2015) Latarsha J. Carithers et al. Biopreservation and Biobanking
- S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase
- (2015) Pulin Che et al. Scientific Reports
- Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells
- (2015) Wolfgang Hagmann et al. NEOPLASIA
- Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma
- (2014) Kateryna Kondratska et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- (2014) D. Raha et al. CANCER RESEARCH
- The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells
- (2014) Frederik Köpper et al. CELL CYCLE
- Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer
- (2014) Pei-Wen Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Involvement of p38 mitogen-activated protein kinase in acquired gemcitabine-resistant human urothelial carcinoma sublines
- (2014) Yu-Ting Kao et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Comparative Proteomic Profiling of Pancreatic Ductal Adenocarcinoma Cell Lines
- (2014) Yikwon Kim et al. MOLECULES AND CELLS
- The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells
- (2014) TEIN-MING YUAN et al. ONCOLOGY REPORTS
- Mass Spectrometry-Based Metabolic Profiling of Gemcitabine-Sensitive and Gemcitabine-Resistant Pancreatic Cancer Cells
- (2014) Yoshinori Fujimura et al. PANCREAS
- PharmGKB summary
- (2014) Maria L. Alvarellos et al. Pharmacogenetics and Genomics
- Cell fate regulation by gelsolin in human gynecologic cancers
- (2014) Mohammad R. Abedini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- The Genotype-Tissue Expression (GTEx) project
- (2013) John Lonsdale et al. NATURE GENETICS
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase
- (2013) N Weizman et al. ONCOGENE
- Double inhibition of NF-κB and XIAP via RNAi enhances the sensitivity of pancreatic cancer cells to gemcitabine
- (2013) LI-PING CAO et al. ONCOLOGY REPORTS
- Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients
- (2013) RADOSŁAW MLAK et al. ONCOLOGY REPORTS
- The Expression of S100A4 in Human Pancreatic Cancer Is Associated With Invasion
- (2013) Nobukazu Tsukamoto et al. PANCREAS
- RRM2B Suppresses Activation of the Oxidative Stress Pathway and is Up-regulated by P53 During Senescence
- (2012) Mei-Ling Kuo et al. Scientific Reports
- Effect of its deaminated metabolite, 2′,2′-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cells
- (2011) L.S. Hodge et al. BIOCHEMICAL PHARMACOLOGY
- Creatine kinase brain overexpression protects colorectal cells from various metabolic and non-metabolic stresses
- (2011) Steven M. Mooney et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells
- (2011) Yi-Wen Chen et al. Molecular BioSystems
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Calbindin 2 (CALB2) Regulates 5-Fluorouracil Sensitivity in Colorectal Cancer by Modulating the Intrinsic Apoptotic Pathway
- (2011) Leanne Stevenson et al. PLoS One
- Overexpression of S100A4 in human cancer cell lines resistant to methotrexate
- (2010) Nuria Mencía et al. BMC CANCER
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis
- (2010) Jennifer S. Carew et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
- (2010) Lars Petter Jordheim et al. LANCET ONCOLOGY
- Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma
- (2010) Natini Jinawath et al. PLoS One
- S100A4 and Metastasis
- (2009) Kjetil Boye et al. AMERICAN JOURNAL OF PATHOLOGY
- RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells
- (2009) Takahiro Tabata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
- (2009) Z. Wang et al. CANCER RESEARCH
- CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
- (2009) Sung Pil Hong et al. INTERNATIONAL JOURNAL OF CANCER
- Implication of Checkpoint Kinase-dependent Up-regulation of Ribonucleotide Reductase R2 in DNA Damage Response
- (2009) Yong-Wei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IDPicker 2.0: Improved Protein Assembly with High Discrimination Peptide Identification Filtering
- (2009) Ze-Qiang Ma et al. JOURNAL OF PROTEOME RESEARCH
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
- (2009) H Akita et al. ONCOGENE
- Pharmacokinetics of Gemcitabine and Metabolites in a Patient with Double-Sided Nephrectomy: A Case Report and Review of the Literature
- (2009) S. L.W. Koolen et al. ONCOLOGIST
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Broad Overexpression of Ribonucleotide Reductase Genes in Mice Specifically Induces Lung Neoplasms
- (2008) X. Xu et al. CANCER RESEARCH
- Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death
- (2008) Vitalia Sagulenko et al. CARCINOGENESIS
- Efficacy of Gemcitabine in Patients with Non-Small Cell Lung Cancer According to Promoter Polymorphisms of the Ribonucleotide Reductase M1 Gene
- (2008) S.-O. Kim et al. CLINICAL CANCER RESEARCH
- Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
- (2008) M. P. Kim et al. CLINICAL CANCER RESEARCH
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
- Measurement of Plasma Concentration of Gemcitabine and Its Metabolite dFdU in Hemodialysis Patients with Advanced Urothelial Cancer
- (2008) N. Masumori et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started